N-heterocyclic inhibitors of TNF-α expression

A compound of Formula (I),

• or enantiomers, diastereomers, tautomers, and pharmaceutically acceptable salts thereof,
• wherein:
• Y and X are ═N—;
• is selected from ═C—CN, ═C—F, ═C—Br, ═C—NH2, ═C—NHC(O)CH3 and ═C—Cl;
• V is —NR5—;
• Z is halogen or —N(R1)(R2);
• R1 and R2 are the same or different and are selected from hydrogen, alkyl, substituted alkyl, cycloalkyl, substituted cycloalkyl, saturated heterocyclyl or substituted saturated heterocyclyl;
• R5 is hydrogen or alkyl;
• R6 is
• R7 is alkyl, substituted alkyl, alkoxy, or halogen;
• R8 is hydrogen, alkyl, alkyloxy or cyano;
• R9 is —C(O)R10 or unsubstituted or substituted heterocyclyl;
• R10 is —N(R31)(R32);
• R31 and R32 are the same or different and are selected from hydrogen, alkyl, substituted alkyl, alkoxy, aryl, substituted aryl, cycloalkyl, substituted cycloalkyl, heterocyclyl or substituted heterocyclyl;
• and
• R11 is hydrogen or halogen.